Systematic review of exposure to albendazole or mebendazole during pregnancy and effects on maternal and child outcomes, with particular reference to exposure in the first trimester

•Evidence on exposure to albendazole or mebendazole in pregnancy is heterogeneous.•No additional risk of adverse birth outcomes was found with first trimester exposure.•Future research should report benzimidazole exposure by trimester.